Nanotherapeutics Overview
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Nanotherapeutics General Information
Description
Manufacturer of injectable polio vaccines designed for polio prevention. The company's facility operates a large-scale manufacturing site specialized for injectable vaccine production and technical research capacity, providing healthcare providers and government health agencies with pharmaceutical products to support immunization programs.
Contact Information
Corporate Office
- Czech Republic
Corporate Office
- Czech Republic
Nanotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nanotherapeutics Signals
Nanotherapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nanotherapeutics FAQs
-
Where is Nanotherapeutics headquartered?
Nanotherapeutics is headquartered in Czech Republic.
-
What is the size of Nanotherapeutics?
Nanotherapeutics has 50 total employees.
-
What industry is Nanotherapeutics in?
Nanotherapeutics’s primary industry is Pharmaceuticals.
-
Is Nanotherapeutics a private or public company?
Nanotherapeutics is a Private company.
-
What is the current valuation of Nanotherapeutics?
The current valuation of Nanotherapeutics is .
-
What is Nanotherapeutics’s current revenue?
The current revenue for Nanotherapeutics is .
-
Who are Nanotherapeutics’s investors?
Baxter International, Ology Bioservices, and Serum Institute of India have invested in Nanotherapeutics.
-
Who acquired Nanotherapeutics?
Nanotherapeutics was acquired by Novavax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process